<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="146461">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02123186</url>
  </required_header>
  <id_info>
    <org_study_id>201308058RIN</org_study_id>
    <nct_id>NCT02123186</nct_id>
  </id_info>
  <brief_title>Newborn Screening for Spinal Muscular Atrophy</brief_title>
  <official_title>Newborn Screening for Spinal Muscular Atrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <authority>Taiwan: Department of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test if the routine newborn screening dried blood spots can be used to test if missing 2
      copies of SMN1 gene, a status indicating spinal muscular atrophy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parents of newborns will be invited to test if their newborns are affected with SMA. The
      routine newborn screening dried blood spots sample will be used to test if missing 2 copies
      of SMN1 gene. If positive of screening test, further confirmation tests including physical
      examination and other methology for SMN1 gene copies quantification will be provided.
      Genetic counseling and treatment option will be provided, too.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>numbers of newborn with spinal muscular atrophy</measure>
    <time_frame>18 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60000</enrollment>
  <condition>Spinal Muscular Atrophy</condition>
  <arm_group>
    <arm_group_label>newborns testing for SMA</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>newborn screening test for SMA</intervention_name>
    <description>Routine newborn screening dried blood spots sample is used to test if missing 2 copies of SMN1 gene.</description>
    <arm_group_label>newborns testing for SMA</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        newborns whose parents agree to be tested
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Babies born in Taiwan receive regular new born screening suggested by Ministry of
             Heath and Welfare.

          -  Parents or Legal Guardian sign in the informed consent form.

        Exclusion Criteria:

          -  Parents or Legal Guardian do not agree to sign in the informed consent form.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yin-Hsiu Chien, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <state>Taiwan,</state>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 23, 2014</lastchanged_date>
  <firstreceived_date>April 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Newborn Screening , spinal muscular atrophy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Muscular Atrophy</mesh_term>
    <mesh_term>Muscular Atrophy, Spinal</mesh_term>
    <mesh_term>Atrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
